: $Actelis Networks(ASNS)$ 中概退潮,玩你们俩兄弟够了,神经病一样的庄,疯狂的手法查看全文
usbiostock2018-06-28 19:46
$Arsanis, Inc.(ASNS)$ 公司宣布ASN100预防金黄色葡萄球菌肺炎临床2期试验未能达到主要终点,公司将终止该药的研发。公司重点将放在ASN500,用于预防呼吸道合胞病毒感染。查看全文
美股医药Z博士2017-12-12 11:33
$Arsanis, Inc.(ASNS)$ 来推荐一只IPO不久的股票,喜欢短线的朋友可以关注。公司具有很多极具潜力的单抗抗生素药物,目前股价已跌破发行价。今日两大投行提高它的评级,并给出23的目标价,结果有意思的是股价居然-12%。是个不错的短线机会,第一个目标价16左右。查看全文
$Actelis Networks(ASNS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-22-080901 Size: 6 KB 网页链接
$Actelis Networks(ASNS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-22-080889 Size: 6 KB 网页链接
$Actelis Networks(ASNS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-22-080896 Size: 6 KB 网页链接
$Actelis Networks(ASNS)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001213900-22-076699 Act: 34 Size: 6 MB 网页链接
$Actelis Networks(ASNS)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001213900-22-074380 Act: 34 Size: 217 KB 网页链接
$Actelis Networks(ASNS)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-22-071536 Act: 34 Size: 369 KB 网页链接
$Actelis Networks(ASNS)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-22-071537 Act: 34 Size: 4 MB 网页链接
$Actelis Networks(ASNS)$ 8-K Current report, item 3.01 Accession Number: 0001213900-22-069412 Act: 34 Size: 202 KB 网页链接
$Actelis Networks(ASNS)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001213900-22-065853 Act: 34 Size: 220 KB 网页链接
$Actelis Networks(ASNS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-22-056973 Size: 6 KB 网页链接